Skip to content

Clinical trials

Recruiting Phase 3 Atrial Fibrillation trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 3 Status: Recruiting Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20192
20201
20222
20235
20243
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Regeneron Pharmaceuticals2
Region Stockholm2
Anthos Therapeutics, Inc.1
Charles University, Czech Republic1
Herlev and Gentofte Hospital1
Hippocration General Hospital1
Icahn School of Medicine at Mount Sinai1
Jilin Heart Hospital1
Johns Hopkins University1
Milestone Pharmaceuticals Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation21
Cerebral Hemorrhage3
Ischemic Stroke3
Stroke3
Hemorrhage2
Thrombosis2
Acute Kidney Injury1
Arrhythmias, Cardiac1
Death1
Diabetes Mellitus1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.